Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.
Consensus
Hold3.33 / 5
6 ratings · Buy 2 · Hold 4
1 rating older than 2 years not counted
Price vs analyst targets
Revenue and EPS estimates
Reported
Consensus estimates
Fiscal period
FY2023Dec '23
FY2024Dec '24
FY2025Dec '25
FY2026Dec '26
FY2027Dec '27
FY2028Dec '28
Revenue (B)
3.01
2.93
3.18
3.35
3.67
3.90
Growth YoY
+13.3%
−2.5%
+8.7%
+5.1%
+9.6%
+6.3%
High estimate
–
–
–
3.39
3.79
3.99
Low estimate
–
–
–
3.32
3.60
3.82
Analysts
–
–
–
5
5
4
EPS, adjusted
−11.77
−19.65
−13.71
−3.12
4.84
8.52
Growth YoY
n/m
n/m
n/m
n/m
n/m
+76.2%
High estimate
–
–
–
−3.08
8.52
8.72
Low estimate
–
–
–
−3.15
1.15
8.35
Analysts
–
–
–
2
2
1
Consensus mean of analyst estimates. EPS is adjusted (street) EPS, the basis analysts forecast; annual actuals are the sum of the four reported quarters. Growth compares with the same period a year earlier; n/m where the prior period was a loss.
Brokers
7 firms active in the last 12 months
Firm
Analyst
Rating
Prev rating
Target
Prev target
Chg
Upside
Date
Barclays
Eddie Kim
Equal Weight
Equal Weight
$93.00
$50.00
+86%
+10%
Nov 9
Citigroup
–
Neutral
Neutral
–
–
–
–
Nov 4
Piper Sandler
Derek Podhaizer
Overweight
Overweight
$130.00
$84.00
+55%
+54%
Nov 3
Susquehanna
Charles Minervino
Neutral
Neutral
$91.00
$85.00
+7%
+7%
Oct 5
Morgan Stanley
–
Overweight · Apr 2026
Overweight
$110.00
$100.00
+10%
+30%
Aug 20
RBC Capital
–
Sector Perform
Sector Perform
$77.00
$70.00
+10%
−9%
Apr 30
UBS
–
Neutral · Nov 2020 · not counted
Neutral
$70.00
–
–
−17%
Feb 13
Latest analyst action · Page refreshed hourly; analyst feeds refreshed daily · About this data
